Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00488878 · ClinicalTrials.gov registry record
Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors
A clinical trial of Ovarian Carcinoma and Primary Peritoneal Carcinoma, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT00488878 is a study of Ovarian Carcinoma and Primary Peritoneal Carcinoma that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 2,000 participants, below the 3,187-participant average among 35 other Ovarian Carcinoma trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00488878, a study of Ovarian Carcinoma and Primary Peritoneal Carcinoma, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This study collects information to maintain a database on patients with low-grade ovarian or peritoneal tumors. Collecting information about the type of cancer and treatment, as well as details about follow-up care, may help researchers learn and better understand these tumor types and help develop better treatments for them.
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Electronic Health Record Review
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2006-05-19 |
| Est. Completion | 2035-05-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00488878
The ClinicalTrials.gov registry entry for NCT00488878 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,187-participant average among 35 other Ovarian Carcinoma trials with a reported enrollment target (37% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Ovarian Carcinoma appearing as the primary indexed condition, and to 2 interventions - of which Biospecimen Collection is the first listed.
NCT00488878 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00488878 about?
NCT00488878 is a clinical study titled "Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors". This study collects information to maintain a database on patients with low-grade ovarian or peritoneal tumors. Collecting information about the type of cancer and treatment, as well as details about follow-up care, may help researchers learn and better understand these tumor types and help develop ...
What is the current status of trial NCT00488878?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2006-05-19. Estimated completion is 2035-05-01.
What conditions does trial NCT00488878 study?
This clinical trial studies the following conditions: Ovarian Carcinoma, Primary Peritoneal Carcinoma, Low Grade Ovarian Serous Adenocarcinoma, Malignant Ovarian Neoplasm, Primary Peritoneal Low Grade Serous Adenocarcinoma.
What interventions are being tested in trial NCT00488878?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Electronic Health Record Review (OTHER).
Who is sponsoring clinical trial NCT00488878?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00488878 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ovarian Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer
RECRUITING · NA
-
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
RECRUITING · NA
-
Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers
RECRUITING · Phase 2
-
Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF
RECRUITING · Phase 1
-
Ultrasound Microvessel Imaging for the Evaluation of Ovarian and Adnexal Lesions
RECRUITING · NA
-
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.